Tag: Cancer: Lung
CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer
Serum CKAP4 levels of lung cancer patients significantly higher than those of healthy controls
Clinical Upstaging of NSCLC Seen With Each Progressive Week
For clinical stage 1 NSCLC, 21.7 percent of patients upstaged after 1 week; 31.5 percent after 8 weeks
Adjuvant Pembrolizumab Beneficial in Metastatic NSCLC
And, nivolumab plus ipilimumab linked to better survival in NSCLC with high tumor mutational burden
Lag in Progress Against Lung CA Mortality in Midwest, Appalachia
Findings based on rates among women versus steady decline seen nationally
Mortality Impacted by Treatment Modality, Age in Early Lung CA
Mortality differed between surgery and radiotherapy; increased age had higher mortality after surgery
Lung Cancer Screening More Efficient for Those at Higher Risk
Initial screens were least effective and least efficient for veterans with lowest lung cancer risk
Race, Education Level Predict CRT in Very Elderly With NSCLC
In elderly with stage III lung cancer, black race, lower-educated county tied to not receiving care
Cancer Probability Documentation Lacking for Some at High Risk
Documentation found to be rarely provided for high-risk indeterminate pulmonary nodes
Lobectomy Beats SBRT Survival in Early-Stage NSCLC
Higher cancer mortality for SBRT versus lobectomy; no difference for SBRT, sublobar resection
Mortality Up for Some Cancers in Urban-Dwelling Native Americans
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
